Thiazolidinediones and Blood Lipids in Type 2 Diabetes
نویسندگان
چکیده
منابع مشابه
Thiazolidinediones and blood lipids in type 2 diabetes.
We evaluated study population characteristics and treatment effects on blood lipids between studies in which either rosiglitazone (RSG) or pioglitazone (PIO) was investigated in patients with type 2 diabetes. We performed a summary analysis of all published double-blind, placebo-controlled studies with RSG (4 and 8 mg/d) and PIO (15, 30, and 45 mg/d). Data were analyzed by the random-effects mo...
متن کاملEffects of Short-term Exercise Program on Blood Glucose, Lipids, and HbA1c in Type 2 Diabetes
OBJECTIVE: For decades, exercise has been considered as a cornerstone for managing diabetes. The current study aimed to determine the effects of short-term exercise on blood glucose, lipids and HbA1C in type-2 diabetes mellitus. MATERIALS AND METHODS: A total of 61 diabetic patients were randomly selected. Later, subjects with capability of doing exercise took part in a special four-week exerc...
متن کاملThe effect of cinnamon on blood lipids profile in patients with type 2 diabetes
Introduction: Metabolic syndrome is increasing with progressive syrup in all age groups. It has become a serious health problem in the community. Today, a number of researches have focused on determining the anti-fat effects of cheap and highly safe herbal products. Cinnamon, one of these herbs, has the ability to lower blood lipids due to its cinnamaldehyde element. Hence, the aim of this stud...
متن کاملNo Association between Serum Lipids Levels and Lipids Oxidizability in Type 2 Diabetes
Objective: Diabetes is the most common metabolic disease. One of the most common problems in diabetic patients is atherosclerotic cardiovascular disease which induced by hyperlipidemia. Also there has been currently great interest in the potential contribution of oxidative stress in development of diabetes complications. The present study was performed to associate between lipid oxidizability a...
متن کاملType 2 diabetes, thiazolidinediones, and cardiovascular risk.
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achieving adequate glycaemic control is an important aim of therapy. Thiazolidinediones, or glitazones, have been used for the treatment of diabetes for a decade. Rosiglitazone and pioglitazone are currently available, however recent concerns around cardiovascular safety have led to restrictions on their...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arteriosclerosis, Thrombosis, and Vascular Biology
سال: 2003
ISSN: 1079-5642,1524-4636
DOI: 10.1161/01.atv.0000090521.25968.4d